SlideShare a Scribd company logo
1 of 57
Approach to a patient
with Vasculitis
Dr. Amina Nur Nova
Resident, Phase-A
Internal medicine
BSMMU
What does vasculitis mean ?
 Vasculitis means inflammation and damage to the blood vessel
wall
 Any type of blood vessel in any organ can be affected
 Patients can present with a wide spectrum of clinical
manifestations ranging from isolated cutaneous vasculitis to
multisystem involvement
 Vasculitis can occur as a primary disorder or secondary to
various medical conditions.
PATHOLOGICAL CHANGES
• Systemic inflammatory response
• Thinning of vessel wall
• Narrowing or complete occlusion of
affected vessel
PATHOGENESIS
1. Immune complex formation
2. ANCA mediated
3. T lymphocyte mediated - with Granuloma
formation
Immune complex formation
• Henoch Schonlein purpura- IgA mediated
• SLE & other collagen vascular diseases- ANA
• Polyarteritis Nodosa- Hepatitis B ag
• Essential Mixed Cryoglobulinaemia- Hepatitis C virion
ANCA
• p-ANCA (anti-proteinase 3)-
 Wegener’s Granulomatosis
• c-ANCA (anti-MPO)
Churg Strauss vasculitis
Microscopic Polyangiitis
Granuloma formation
(T lymphocyte mediated)
• Giant cell arteritis
• Takayasu’s arteritis
• Wegener’s granulomatosis
• Churg Strauss vasculitis
Classification
• Primary
• Secondary
Primary Vasculitis
Large vessel vasculitis
 Giant cell arteritis
 Takayasu’s arteritis
Medium vessel Vasculitis
 Poly Arteritis Nodosa
 Kawasaki’s disease
Small vessel Vasculitis
 Wegener’s Granulomatosis
 Churg Strauss syndrome
 Microscopic Polyangiitis
 Henoch Schonlein Purpura
 Essential Mixed Cryoglobulinemia
Other primary vasculitis
 Thromb Angiitis Obliterans
 Behcet’s disease
 Idiopathic Cutaneous vasculitis
 Isolated Vasculitis of CNS
 Relapsing Polychondritis
 Polyangiitis overlap syndromes (features of
more than 1 vasculitis)
Secondary Vasculitis
• Connective tissue disorders
– rheumatoid vasculitis,
– lupus erythematosus,
– Sjögren's syndrome,
– inflammatory myopathies
• Inflammatory bowel disease
• Paraneoplastic
• Infection
• Drug-induced vasculitis
STEP 1
When to suspect vasculitis
• Multi-system involvement
• Unexplained fever, weight loss.
• Unexplained raised ESR or CRP
• Occlusive arterial disease or hypertension in young
adults.
• Cerebrovascular/cardiovascular events in young.
• Unexplained proteinuria with or without casts.
• Splinter haemorrhages in nails
 Cutaneous lesions - palpable purpura,
erythema, subcutaneous nodules or urticaria.
 Sudden retinal vascular disease without
hypertension or diabetes
 Sudden appearance of peripheral neuropathy -
wrist drop, foot drop.
 Unexplained finding of pulmonary
nodular/cavitatory lesions.
 Persistent headache with sudden visual
impairment (monocular blindness) in elderly.
 Jaw claudication
Palpable purpura
Pulmonary infiltrates
Microscopic hematuria
STEP 2
RULE OUT DISEASES THAT
MIMIC VASCULITIS
• Infections
• Malignancies
• Thrombotic Microangiopathies
• Drugs
• Others
Infections
• Bacterial endocarditis
• Gonococcal Infection
• Syphilis
• Rickettsial diseases
• Histoplasmosis
• Coccidiomycosis
• Whipple’s
• Lyme’s
Malignancies
• Atrial Myxomas
• Carcinomatosis
• Lymphomas
Thrombotic Microangiopathies
• TTP
• HUS
Drugs
• Cocaine
• Phenytoin
• Sulfa drugs
• Penicillins
• Hydralazine
• Allopurinol
• Propylthiouracil
• Thiazides
Others
• SLE
• Amyloidosis
• Sarcoidosis
• Atheroembolic Disease
STEP 3
THE PATTERN OF VESSEL
INVOLVEMENT
(Large vessel, Medium vessel, Small
vessel)
Clinical features of vasculitis on
the basis of size of the affected
blood vessel
Size of blood vessel Blood vessel involved Clinical features
Small vessel vasculitis  Cutaneous
post‐capillary
venules
 Glomerular
capillaries
 Pulmonary
capillaries
• Palpable purpura
• Haematuria, red cell
casts, proteinuria,
and decline in renal
function
• Lung haemorrhage
manifesting as
breathlessness,
haemoptysis and
widespread alveolar
shadowing on chest
radiograph
Size of blood vessel Blood vessel involved Clinical features
Medium vessel vasculitis  Small cutaneous arteries
 Epineural arteries
 Mesenteric artery
 Branches of coeliac artery
 Renal artery
 Coronary arteries
 Small pulmonary arteries
 Small arteries in ear, nose
and throat region
 Necrotic lesions and
ulcers, nail fold infarcts
 Mononeuritis multiplex
 Abdominal pain,
gastrointestinal bleeding
and perforation because of
gut infarction
 Infarction of liver, spleen,
or pancreas
• Renal infarction
 Myocardial infarction or
angina, coronary artery
aneurysm, ischaemic
cardiomyopathy
 Necrotic lesions leading to
cavitating lung shadows
on chest radiograph
 Nasal crusting, epistaxis,
sinusitis, deafness, stridor
because of sub‐glottic
stenosis
Size of blood vessel Blood vessel involved Clinical features
Large vessel
vasculitis (aorta and
its branches)
 Extracranial
branches of
carotid artery
 Thoracic aorta and
its branches
 Temporal
headache
(temporal artery),
blindness
(ophthalmic
artery), jaw
claudication
(vessels supplying
muscles of
mastication)
 Limb claudication,
absent pulses and
unequal blood
pressure, bruits,
thoracic aortic
aneurysms
STEP 4
Learn the characteristic
presentations of each vasculitis
Giant Cell Arteritis
• Can occur exclusively but often seen
with PMR
• Rare: 15/100,000
• Age >50
• Cause unknown
• Involves the large blood vessels of the
head and neck including the blood
vessels that supply the optic nerve
MEDIUM VESSEL VASCULITIS
Poly Arteritis Nodosa
• Renal arteries most commonly involved leading to
renovascular hypertension
• Pulmonary vessels NEVER involved
• Association with patients of
o Hepatitis B
o Hairy cell leukemia
Clinical Presentation
• Systemic: fever, fatigue, wt loss
• Abdominal pain due to mesenteric angina/ischemia
• Mononeuritis multiplex
• Myalgias/arthalgias/mild arthritis
• Renal: uremia, Hypertension
• Skin: livedo reticularis, fingertip ulceration,
subcutaneous nodules
• Testicular pain or tenderness
Wegener’s Granulomatosis
• Classical triad  URT + LRT + renal
• Chronis sinusitis, Pulmonary nodules, Pulmonary
cavities, Rapidly Progressive Glomerulonephritis
• Cutaneous vasculitis, Eye lesions may be present
• Non specific symptoms may predominate
Churg Strauss syndrome
• Also known as Allergic Granulomatosis
• Site: Blood vessels of the lungs
GI Tract
Peripheral nerves
Heart, skin, and kidneys
• Presence of 4 or more criteria:-
(1) H/O Bronchial asthma
(2) Eosinophilia >10% in Peripheral Blood
(3) Paranasal sinusitis
(4) Pulmonary infiltrates (Transient)
(5) Histology: vasculitis with extravascular eosinophils
(6) Mononeuritis multiplex or Polyneuropathy
Henoch-Schönlein Purpura
Also referred to as anaphylactoid purpura
 Age at onset ≤20 years
 palpable purpura (most commonly distributed over
the
buttocks and lower extremities)
 Arthralgias
 Bowel angina
 Gastrointestinal bleeding
 Haematuria
 No new medication
Essential Mixed
Cryoglobulinemia
• 5 % of Chronic Hepatits C pts
• Cryoglobulins formed agianst HCV RNA
• Pulmonary, renal ( MPGN ), cutaneous vasculitis
Thromb Angiitis Obliterans
• Chronic heavy Smokers
• Inflammation of arteries, veins, nerves
• Upper and lower limb gangrene, claudication pain,
rest pain
Step 5
How to diagnose
vasculitis???
• To exclude vasculitis ‘‘mimics’’ and secondary
causes
• Blood cultures
• Echocardiogram
• Hepatitis screen (B and C)
• HIV test
• Antiglomerular basement membrane antibody
• Antiphospholipid antibodies
• Antinuclear antibody
 To assess extent of vasculitis
 Urine dipstick and microscopy (all patients)
 Chest radiography (all patients)
 Nerve conduction
studies/electromyography/CK
 To confirm diagnosis of vasculitis
 Biopsy and/or angiogram
 To identify the specific type of vasculitis
 ANCA
 Cryoglobulin
 Complement levels
 Eosinophil counts/IgE levels
 Specific findings on biopsy (necrotising
granulomatous inflammation, presence of IgA
deposits, evidence of immune complex formation
(or its absence))
ANCA
Two types of ANCA staining patterns are seen on
immunofluorescence (IF), namely cytoplasmic (c-ANCA) and
perinuclear (p-ANCA).
 ELISA should then always be performed in patients with positive
results on immunofluorescence (IF) to identify the specific
antigen targeted by ANCA
 Presence of c-ANCA with anti-proteinase 3 (anti-PR3) is highly
suggestive of Wegener’s granulomatosis while p- ANCA with
anti-myeloperoxidase (anti-MPO) is more often encountered in
those Churg-Strauss syndrome and microscopic polyangiitis
For a positive IF test alone, sensitivity for AAV is
around 67% and specificity is around 93%.
 For combined IF and ELISA, sensitivity decreases to
around 52%, but specificity increases to 99%.
• It is worth mentioning here that false positive ANCA
results could be seen in a wide variety of conditions
especially when positive IF results are not confirmed
by ELISA
 Conversely, ANCA can be negative in a significant
proportion of patients with AAV (10%–20% of active,
untreated Wegener’s granulomatosis, 30% of limited
Wegener’s granulomatosis, 30% of MPA, and 50% of
Churg-Strauss syndrome patients in most series)
 Thus, ANCA test should not be requested unless there is
clinical suspicion of vasculitis and its absence should not be
taken as evidence against AAV.
THANK YOU

More Related Content

What's hot

What's hot (20)

Vasculitis
VasculitisVasculitis
Vasculitis
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Churg strauss syndrome
Churg strauss syndromeChurg strauss syndrome
Churg strauss syndrome
 
ANCA vasculitis
ANCA vasculitisANCA vasculitis
ANCA vasculitis
 
Approach to a patient with vasculitis and its
Approach to a patient with vasculitis and itsApproach to a patient with vasculitis and its
Approach to a patient with vasculitis and its
 
granulomatosis with polyangiitis (Wegener’s granulomatosis)
granulomatosis with polyangiitis (Wegener’s granulomatosis) granulomatosis with polyangiitis (Wegener’s granulomatosis)
granulomatosis with polyangiitis (Wegener’s granulomatosis)
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
Polyarteritis nodosa
Polyarteritis nodosaPolyarteritis nodosa
Polyarteritis nodosa
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
ANCA
ANCA ANCA
ANCA
 
Vasculitis syndromes
Vasculitis syndromesVasculitis syndromes
Vasculitis syndromes
 
Polyarteritis nodosa
Polyarteritis nodosaPolyarteritis nodosa
Polyarteritis nodosa
 
THE VASCULITIS SYNDROME
THE VASCULITIS SYNDROMETHE VASCULITIS SYNDROME
THE VASCULITIS SYNDROME
 
THROMBOTIC MICROANGIOPATHY
THROMBOTIC MICROANGIOPATHY THROMBOTIC MICROANGIOPATHY
THROMBOTIC MICROANGIOPATHY
 
Approach to the patient vasculitis (2)
Approach to the patient vasculitis (2)Approach to the patient vasculitis (2)
Approach to the patient vasculitis (2)
 
Systematization and diagnosis of vasculitides. Mikhail Valivach
Systematization and diagnosis of vasculitides. Mikhail ValivachSystematization and diagnosis of vasculitides. Mikhail Valivach
Systematization and diagnosis of vasculitides. Mikhail Valivach
 
Dermatomyositis Dr. Saad Raheem Abed
Dermatomyositis Dr. Saad Raheem AbedDermatomyositis Dr. Saad Raheem Abed
Dermatomyositis Dr. Saad Raheem Abed
 
Polyarteritis nodosa
Polyarteritis nodosaPolyarteritis nodosa
Polyarteritis nodosa
 
Takayasu arteritis
Takayasu arteritisTakayasu arteritis
Takayasu arteritis
 

Similar to Approach to a patient with vasculitis

Vasculitis 130522234019-phpapp02
Vasculitis 130522234019-phpapp02Vasculitis 130522234019-phpapp02
Vasculitis 130522234019-phpapp02Gordhan Das asani
 
Dermatology(saculitis)
Dermatology(saculitis)Dermatology(saculitis)
Dermatology(saculitis)Viju Rathod
 
meidicine.Vasculitis 1.(dr.kawa)
meidicine.Vasculitis 1.(dr.kawa)meidicine.Vasculitis 1.(dr.kawa)
meidicine.Vasculitis 1.(dr.kawa)student
 
APPROACH TO VASCULITIS..........pptx
APPROACH TO VASCULITIS..........pptxAPPROACH TO VASCULITIS..........pptx
APPROACH TO VASCULITIS..........pptxKrishnaGajjar9
 
Imaging of vasculitis
Imaging of vasculitis Imaging of vasculitis
Imaging of vasculitis Ahmed Bahnassy
 
VASCULITIS AND UPDATES.pptx
VASCULITIS  AND UPDATES.pptxVASCULITIS  AND UPDATES.pptx
VASCULITIS AND UPDATES.pptxBVDUPathology1
 
04 vascular pathology
04 vascular pathology04 vascular pathology
04 vascular pathologymed_students0
 
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptxD. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptxhussainAltaher
 
Vaskulitis/ Giant cell arteritis/ temporalis arteritis
Vaskulitis/ Giant cell arteritis/ temporalis arteritisVaskulitis/ Giant cell arteritis/ temporalis arteritis
Vaskulitis/ Giant cell arteritis/ temporalis arteritisAzfahsyaRafifYusro
 
Pulmonary vasculitis(wegner,s granulomatosis)
Pulmonary vasculitis(wegner,s granulomatosis)Pulmonary vasculitis(wegner,s granulomatosis)
Pulmonary vasculitis(wegner,s granulomatosis)Ratanmeena
 
Lecture_13,14 Vasculitis and JIA.pptx
Lecture_13,14 Vasculitis and JIA.pptxLecture_13,14 Vasculitis and JIA.pptx
Lecture_13,14 Vasculitis and JIA.pptxTorprojectTor
 
vasculitis syndromes in rheumatology.pptx
vasculitis syndromes in rheumatology.pptxvasculitis syndromes in rheumatology.pptx
vasculitis syndromes in rheumatology.pptxsolankiumesh45
 
Vasculitides AND ANTI-GBM
Vasculitides AND ANTI-GBMVasculitides AND ANTI-GBM
Vasculitides AND ANTI-GBMAnass Qasem
 
Diagnosis of vasculitides and pseudovasculitides. A quick reference guide. Mi...
Diagnosis of vasculitides and pseudovasculitides. A quick reference guide. Mi...Diagnosis of vasculitides and pseudovasculitides. A quick reference guide. Mi...
Diagnosis of vasculitides and pseudovasculitides. A quick reference guide. Mi...Mikhail Valivach
 
Vasculitis pathology
Vasculitis pathologyVasculitis pathology
Vasculitis pathologySaachiGupta4
 

Similar to Approach to a patient with vasculitis (20)

Vasculitis 130522234019-phpapp02
Vasculitis 130522234019-phpapp02Vasculitis 130522234019-phpapp02
Vasculitis 130522234019-phpapp02
 
Dermatology(saculitis)
Dermatology(saculitis)Dermatology(saculitis)
Dermatology(saculitis)
 
Tutorial vasculitis
Tutorial vasculitisTutorial vasculitis
Tutorial vasculitis
 
meidicine.Vasculitis 1.(dr.kawa)
meidicine.Vasculitis 1.(dr.kawa)meidicine.Vasculitis 1.(dr.kawa)
meidicine.Vasculitis 1.(dr.kawa)
 
APPROACH TO VASCULITIS..........pptx
APPROACH TO VASCULITIS..........pptxAPPROACH TO VASCULITIS..........pptx
APPROACH TO VASCULITIS..........pptx
 
Imaging of vasculitis
Imaging of vasculitis Imaging of vasculitis
Imaging of vasculitis
 
Vasculitis.pptx
Vasculitis.pptxVasculitis.pptx
Vasculitis.pptx
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
VASCULITIS AND UPDATES
VASCULITIS  AND UPDATESVASCULITIS  AND UPDATES
VASCULITIS AND UPDATES
 
VASCULITIS AND UPDATES.pptx
VASCULITIS  AND UPDATES.pptxVASCULITIS  AND UPDATES.pptx
VASCULITIS AND UPDATES.pptx
 
04 vascular pathology
04 vascular pathology04 vascular pathology
04 vascular pathology
 
Vasculitis
VasculitisVasculitis
Vasculitis
 
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptxD. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
D. Fadhil Vasculitis-7 (Muhadharaty) (1).pptx
 
Vaskulitis/ Giant cell arteritis/ temporalis arteritis
Vaskulitis/ Giant cell arteritis/ temporalis arteritisVaskulitis/ Giant cell arteritis/ temporalis arteritis
Vaskulitis/ Giant cell arteritis/ temporalis arteritis
 
Pulmonary vasculitis(wegner,s granulomatosis)
Pulmonary vasculitis(wegner,s granulomatosis)Pulmonary vasculitis(wegner,s granulomatosis)
Pulmonary vasculitis(wegner,s granulomatosis)
 
Lecture_13,14 Vasculitis and JIA.pptx
Lecture_13,14 Vasculitis and JIA.pptxLecture_13,14 Vasculitis and JIA.pptx
Lecture_13,14 Vasculitis and JIA.pptx
 
vasculitis syndromes in rheumatology.pptx
vasculitis syndromes in rheumatology.pptxvasculitis syndromes in rheumatology.pptx
vasculitis syndromes in rheumatology.pptx
 
Vasculitides AND ANTI-GBM
Vasculitides AND ANTI-GBMVasculitides AND ANTI-GBM
Vasculitides AND ANTI-GBM
 
Diagnosis of vasculitides and pseudovasculitides. A quick reference guide. Mi...
Diagnosis of vasculitides and pseudovasculitides. A quick reference guide. Mi...Diagnosis of vasculitides and pseudovasculitides. A quick reference guide. Mi...
Diagnosis of vasculitides and pseudovasculitides. A quick reference guide. Mi...
 
Vasculitis pathology
Vasculitis pathologyVasculitis pathology
Vasculitis pathology
 

Recently uploaded

Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATROKanhu Charan
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt downloadAnkitKumar311566
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...MehranMouzam
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalityhardikdabas3
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxDr. Dheeraj Kumar
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseSreenivasa Reddy Thalla
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityHarshChauhan475104
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfDolisha Warbi
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxdrashraf369
 

Recently uploaded (20)

Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATROApril 2024 ONCOLOGY CARTOON by  DR KANHU CHARAN PATRO
April 2024 ONCOLOGY CARTOON by DR KANHU CHARAN PATRO
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
world health day presentation ppt download
world health day presentation ppt downloadworld health day presentation ppt download
world health day presentation ppt download
 
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
Study on the Impact of FOCUS-PDCA Management Model on the Disinfection Qualit...
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
maternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortalitymaternal mortality and its causes and how to reduce maternal mortality
maternal mortality and its causes and how to reduce maternal mortality
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Radiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptxRadiation Dosimetry Parameters and Isodose Curves.pptx
Radiation Dosimetry Parameters and Isodose Curves.pptx
 
Clinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies DiseaseClinical Pharmacotherapy of Scabies Disease
Clinical Pharmacotherapy of Scabies Disease
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand UniversityCEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
CEHPALOSPORINS.pptx By Harshvardhan Dev Bhoomi Uttarakhand University
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdfPULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
PULMONARY EMBOLISM AND ITS MANAGEMENTS.pdf
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
low cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptxlow cost antibiotic cement nail for infected non union.pptx
low cost antibiotic cement nail for infected non union.pptx
 

Approach to a patient with vasculitis

  • 1. Approach to a patient with Vasculitis Dr. Amina Nur Nova Resident, Phase-A Internal medicine BSMMU
  • 2. What does vasculitis mean ?  Vasculitis means inflammation and damage to the blood vessel wall  Any type of blood vessel in any organ can be affected  Patients can present with a wide spectrum of clinical manifestations ranging from isolated cutaneous vasculitis to multisystem involvement  Vasculitis can occur as a primary disorder or secondary to various medical conditions.
  • 3. PATHOLOGICAL CHANGES • Systemic inflammatory response • Thinning of vessel wall • Narrowing or complete occlusion of affected vessel
  • 4.
  • 5. PATHOGENESIS 1. Immune complex formation 2. ANCA mediated 3. T lymphocyte mediated - with Granuloma formation
  • 6. Immune complex formation • Henoch Schonlein purpura- IgA mediated • SLE & other collagen vascular diseases- ANA • Polyarteritis Nodosa- Hepatitis B ag • Essential Mixed Cryoglobulinaemia- Hepatitis C virion
  • 7. ANCA • p-ANCA (anti-proteinase 3)-  Wegener’s Granulomatosis • c-ANCA (anti-MPO) Churg Strauss vasculitis Microscopic Polyangiitis
  • 8. Granuloma formation (T lymphocyte mediated) • Giant cell arteritis • Takayasu’s arteritis • Wegener’s granulomatosis • Churg Strauss vasculitis
  • 10. Primary Vasculitis Large vessel vasculitis  Giant cell arteritis  Takayasu’s arteritis Medium vessel Vasculitis  Poly Arteritis Nodosa  Kawasaki’s disease
  • 11. Small vessel Vasculitis  Wegener’s Granulomatosis  Churg Strauss syndrome  Microscopic Polyangiitis  Henoch Schonlein Purpura  Essential Mixed Cryoglobulinemia
  • 12. Other primary vasculitis  Thromb Angiitis Obliterans  Behcet’s disease  Idiopathic Cutaneous vasculitis  Isolated Vasculitis of CNS  Relapsing Polychondritis  Polyangiitis overlap syndromes (features of more than 1 vasculitis)
  • 13.
  • 14. Secondary Vasculitis • Connective tissue disorders – rheumatoid vasculitis, – lupus erythematosus, – Sjögren's syndrome, – inflammatory myopathies • Inflammatory bowel disease • Paraneoplastic • Infection • Drug-induced vasculitis
  • 15. STEP 1 When to suspect vasculitis
  • 16. • Multi-system involvement • Unexplained fever, weight loss. • Unexplained raised ESR or CRP • Occlusive arterial disease or hypertension in young adults. • Cerebrovascular/cardiovascular events in young. • Unexplained proteinuria with or without casts. • Splinter haemorrhages in nails
  • 17.  Cutaneous lesions - palpable purpura, erythema, subcutaneous nodules or urticaria.  Sudden retinal vascular disease without hypertension or diabetes  Sudden appearance of peripheral neuropathy - wrist drop, foot drop.  Unexplained finding of pulmonary nodular/cavitatory lesions.  Persistent headache with sudden visual impairment (monocular blindness) in elderly.  Jaw claudication
  • 21. STEP 2 RULE OUT DISEASES THAT MIMIC VASCULITIS
  • 22. • Infections • Malignancies • Thrombotic Microangiopathies • Drugs • Others
  • 23. Infections • Bacterial endocarditis • Gonococcal Infection • Syphilis • Rickettsial diseases • Histoplasmosis • Coccidiomycosis • Whipple’s • Lyme’s
  • 24. Malignancies • Atrial Myxomas • Carcinomatosis • Lymphomas Thrombotic Microangiopathies • TTP • HUS
  • 25. Drugs • Cocaine • Phenytoin • Sulfa drugs • Penicillins • Hydralazine • Allopurinol • Propylthiouracil • Thiazides
  • 26. Others • SLE • Amyloidosis • Sarcoidosis • Atheroembolic Disease
  • 27. STEP 3 THE PATTERN OF VESSEL INVOLVEMENT (Large vessel, Medium vessel, Small vessel)
  • 28. Clinical features of vasculitis on the basis of size of the affected blood vessel Size of blood vessel Blood vessel involved Clinical features Small vessel vasculitis  Cutaneous post‐capillary venules  Glomerular capillaries  Pulmonary capillaries • Palpable purpura • Haematuria, red cell casts, proteinuria, and decline in renal function • Lung haemorrhage manifesting as breathlessness, haemoptysis and widespread alveolar shadowing on chest radiograph
  • 29. Size of blood vessel Blood vessel involved Clinical features Medium vessel vasculitis  Small cutaneous arteries  Epineural arteries  Mesenteric artery  Branches of coeliac artery  Renal artery  Coronary arteries  Small pulmonary arteries  Small arteries in ear, nose and throat region  Necrotic lesions and ulcers, nail fold infarcts  Mononeuritis multiplex  Abdominal pain, gastrointestinal bleeding and perforation because of gut infarction  Infarction of liver, spleen, or pancreas • Renal infarction  Myocardial infarction or angina, coronary artery aneurysm, ischaemic cardiomyopathy  Necrotic lesions leading to cavitating lung shadows on chest radiograph  Nasal crusting, epistaxis, sinusitis, deafness, stridor because of sub‐glottic stenosis
  • 30. Size of blood vessel Blood vessel involved Clinical features Large vessel vasculitis (aorta and its branches)  Extracranial branches of carotid artery  Thoracic aorta and its branches  Temporal headache (temporal artery), blindness (ophthalmic artery), jaw claudication (vessels supplying muscles of mastication)  Limb claudication, absent pulses and unequal blood pressure, bruits, thoracic aortic aneurysms
  • 31. STEP 4 Learn the characteristic presentations of each vasculitis
  • 32. Giant Cell Arteritis • Can occur exclusively but often seen with PMR • Rare: 15/100,000 • Age >50 • Cause unknown • Involves the large blood vessels of the head and neck including the blood vessels that supply the optic nerve
  • 33.
  • 34.
  • 35.
  • 37. Poly Arteritis Nodosa • Renal arteries most commonly involved leading to renovascular hypertension • Pulmonary vessels NEVER involved • Association with patients of o Hepatitis B o Hairy cell leukemia
  • 38. Clinical Presentation • Systemic: fever, fatigue, wt loss • Abdominal pain due to mesenteric angina/ischemia • Mononeuritis multiplex • Myalgias/arthalgias/mild arthritis • Renal: uremia, Hypertension • Skin: livedo reticularis, fingertip ulceration, subcutaneous nodules • Testicular pain or tenderness
  • 39.
  • 40.
  • 41.
  • 42.
  • 43. Wegener’s Granulomatosis • Classical triad  URT + LRT + renal • Chronis sinusitis, Pulmonary nodules, Pulmonary cavities, Rapidly Progressive Glomerulonephritis • Cutaneous vasculitis, Eye lesions may be present • Non specific symptoms may predominate
  • 44.
  • 45. Churg Strauss syndrome • Also known as Allergic Granulomatosis • Site: Blood vessels of the lungs GI Tract Peripheral nerves Heart, skin, and kidneys • Presence of 4 or more criteria:- (1) H/O Bronchial asthma (2) Eosinophilia >10% in Peripheral Blood (3) Paranasal sinusitis (4) Pulmonary infiltrates (Transient) (5) Histology: vasculitis with extravascular eosinophils (6) Mononeuritis multiplex or Polyneuropathy
  • 46.
  • 47. Henoch-Schönlein Purpura Also referred to as anaphylactoid purpura  Age at onset ≤20 years  palpable purpura (most commonly distributed over the buttocks and lower extremities)  Arthralgias  Bowel angina  Gastrointestinal bleeding  Haematuria  No new medication
  • 48.
  • 49. Essential Mixed Cryoglobulinemia • 5 % of Chronic Hepatits C pts • Cryoglobulins formed agianst HCV RNA • Pulmonary, renal ( MPGN ), cutaneous vasculitis Thromb Angiitis Obliterans • Chronic heavy Smokers • Inflammation of arteries, veins, nerves • Upper and lower limb gangrene, claudication pain, rest pain
  • 50. Step 5 How to diagnose vasculitis???
  • 51. • To exclude vasculitis ‘‘mimics’’ and secondary causes • Blood cultures • Echocardiogram • Hepatitis screen (B and C) • HIV test • Antiglomerular basement membrane antibody • Antiphospholipid antibodies • Antinuclear antibody
  • 52.  To assess extent of vasculitis  Urine dipstick and microscopy (all patients)  Chest radiography (all patients)  Nerve conduction studies/electromyography/CK  To confirm diagnosis of vasculitis  Biopsy and/or angiogram
  • 53.  To identify the specific type of vasculitis  ANCA  Cryoglobulin  Complement levels  Eosinophil counts/IgE levels  Specific findings on biopsy (necrotising granulomatous inflammation, presence of IgA deposits, evidence of immune complex formation (or its absence))
  • 54. ANCA Two types of ANCA staining patterns are seen on immunofluorescence (IF), namely cytoplasmic (c-ANCA) and perinuclear (p-ANCA).  ELISA should then always be performed in patients with positive results on immunofluorescence (IF) to identify the specific antigen targeted by ANCA  Presence of c-ANCA with anti-proteinase 3 (anti-PR3) is highly suggestive of Wegener’s granulomatosis while p- ANCA with anti-myeloperoxidase (anti-MPO) is more often encountered in those Churg-Strauss syndrome and microscopic polyangiitis
  • 55. For a positive IF test alone, sensitivity for AAV is around 67% and specificity is around 93%.  For combined IF and ELISA, sensitivity decreases to around 52%, but specificity increases to 99%. • It is worth mentioning here that false positive ANCA results could be seen in a wide variety of conditions especially when positive IF results are not confirmed by ELISA
  • 56.  Conversely, ANCA can be negative in a significant proportion of patients with AAV (10%–20% of active, untreated Wegener’s granulomatosis, 30% of limited Wegener’s granulomatosis, 30% of MPA, and 50% of Churg-Strauss syndrome patients in most series)  Thus, ANCA test should not be requested unless there is clinical suspicion of vasculitis and its absence should not be taken as evidence against AAV.